Bumrungrad Hospital PCL (BK:BH) — Market Cap & Net Worth
Market Cap & Net Worth: Bumrungrad Hospital PCL (BH)
Bumrungrad Hospital PCL (BK:BH) has a market capitalization of $4.58 Billion (฿147.07 Billion) as of June 17, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #3824 globally and #22 in its home market, demonstrating a 0.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bumrungrad Hospital PCL's stock price ฿185.00 by its total outstanding shares 794966592 (794.97 Million). Review Bumrungrad Hospital PCL balance sheet liabilities to assess the company's total debt and financial obligations.
Bumrungrad Hospital PCL Market Cap History: 2015 to 2026
Bumrungrad Hospital PCL's market capitalization history from 2015 to 2026. Data shows growth from $4.44 Billion to $4.58 Billion (0.09% CAGR).
Bumrungrad Hospital PCL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bumrungrad Hospital PCL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.15x
Bumrungrad Hospital PCL's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.52x
Bumrungrad Hospital PCL's market cap is 0.52 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.85 Billion | $17.91 Billion | $3.63 Billion | 0.22x | 1.06x |
| 2017 | $4.08 Billion | $18.35 Billion | $3.94 Billion | 0.22x | 1.03x |
| 2018 | $4.11 Billion | $18.33 Billion | $4.15 Billion | 0.22x | 0.99x |
| 2019 | $3.28 Billion | $18.47 Billion | $3.75 Billion | 0.18x | 0.87x |
| 2020 | $2.75 Billion | $12.36 Billion | $1.20 Billion | 0.22x | 2.28x |
| 2021 | $3.30 Billion | $12.46 Billion | $1.22 Billion | 0.27x | 2.72x |
| 2022 | $5.06 Billion | $20.72 Billion | $4.94 Billion | 0.24x | 1.02x |
| 2023 | $5.38 Billion | $25.38 Billion | $7.01 Billion | 0.21x | 0.77x |
| 2024 | $4.94 Billion | $25.72 Billion | $7.77 Billion | 0.19x | 0.64x |
| 2025 | $3.90 Billion | $25.22 Billion | $7.51 Billion | 0.15x | 0.52x |
Competitor Companies of BH by Market Capitalization
Companies near Bumrungrad Hospital PCL in the global market cap rankings as of June 17, 2026.
Key companies related to Bumrungrad Hospital PCL by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #329 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.58 Billion USD ( €21.88 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1344 globally with a market cap of $19.28 Billion USD ( RM76.79 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #329 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $389.97 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.58 Billion | €38.85 |
| #1344 | IHH Healthcare Bhd | KLSE:5225 | $19.28 Billion | RM8.69 |
Bumrungrad Hospital PCL Historical Marketcap From 2015 to 2026
Between 2015 and today, Bumrungrad Hospital PCL's market cap moved from $4.44 Billion to $ 4.58 Billion, with a yearly change of 0.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿4.58 Billion | +17.46% |
| 2025 | ฿3.90 Billion | -21.05% |
| 2024 | ฿4.94 Billion | -8.13% |
| 2023 | ฿5.38 Billion | +6.43% |
| 2022 | ฿5.06 Billion | +53.04% |
| 2021 | ฿3.30 Billion | +20.33% |
| 2020 | ฿2.75 Billion | -16.21% |
| 2019 | ฿3.28 Billion | -20.18% |
| 2018 | ฿4.11 Billion | +0.64% |
| 2017 | ฿4.08 Billion | +5.86% |
| 2016 | ฿3.85 Billion | -13.14% |
| 2015 | ฿4.44 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Bumrungrad Hospital PCL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.58 Billion USD |
| MoneyControl | $4.58 Billion USD |
| MarketWatch | $4.58 Billion USD |
| marketcap.company | $4.58 Billion USD |
| Reuters | $4.58 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bumrungrad Hospital PCL
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic,… Read more